This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P et al. Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants. Bone Marrow Transplant 2015; 50: 476–482.
Themeli M, Riviere I, Sadelain M . New cell sources for T cell engineering and adoptive immunotherapy. Cell Stem Cell 2015; 16: 357–366.
Granata A, Drezet A, Faucher C, Lemarie C, Calmels B, Chabannon C . New developments in the use of apheresis to collect hematopoietic cells for cell transplantation and cell therapies. ISBT Science Series 2016; 11 (Suppl. 1): 100–104.
Cousins AF, Sinclair JE, Alcorn MJ, HA Green R, Douglas KW . HPC-A dose prediction on the optia(R) cell separator based on a benchmark CE2 collection efficiency: promoting clinical efficiency, minimizing toxicity, and allowing quality control. J Clin Apher 2015; 30: 321–328.
Reinhardt P, Brauninger S, Bialleck H, Thorausch K, Smith R, Schrezenmeier H et al. Automatic interface-controlled apheresis collection of stem/progenitor cells: results from an autologous donor validation trial of a novel stem cell apheresis device. Transfusion 2011; 51: 1321–1330.
Sorensen J, Jarisch A, Smorta C, Kohl U, Bader P, Seifried E et al. Pediatric apheresis with a novel apheresis device with electronic interface control. Transfusion 2013; 53: 761–765.
Steininger PA, Smith R, Geier C, Zimmermann R, Eckstein R, Strasser EF . Leukapheresis in non-cytokine-stimulated donors with a new apheresis system: first-time collection results and evaluation of subsequent cryopreservation. Transfusion 2013; 53: 747–756.
Loaiza S, Haynes R, Bray E, Finn SA, Rezvani K, Apperley J et al. Donor lymphocyte collections using the spectra Optia MNC version 5. Transfus Apher Sci 2013; 48: 171.
Douglas KW, McGarvey M, Robertson S, Sinclair JE, Taylor S, Green RHA . "Will I have enough cells for a transplant, doctor?" Validation of a CD34+ dose prediction formula using patient weight, peripheral CD34+ count and predicted end-run results in a series of 440 consecutive PBSC collection procedures using the MNC program on COBE Spectra. J Clin Apher 2008; 23: 21–22.
Pierelli L, Maresca M, Piccirillo N, Pupella S, Gozzer M, Foddai ML et al. Accurate prediction of autologous stem cell apheresis yields using a double variable-dependent method assures systematic efficiency control of continuous flow collection procedures. Vox Sang 2006; 91: 126–134.
Rosenbaum ER, O’Connell B, Cottler-Fox M . Validation of a formula for predicting daily CD34(+) cell collection by leukapheresis. Cytotherapy 2012; 14: 461–466.
Del Fante C, Scudeller L, Viarengo G, Cervio M, Perotti C . Mononuclear cell collection for extracorporeal photochemotherapy: a study comparing an automatic and a semiautomatic apheresis device. Transfusion 2013; 53: 2027–2033.
Acknowledgements
The authors are grateful to all nursing personnel at the apheresis facility – Centre de Thérapie Cellulaire, Institut Paoli-Calmettes, for their long-term commitment to providing superb care to patients referred to our transplant program. They also wish to express their appreciation to Richard Smith, Nelly Besson and Bernard Gendronneau at Terumo BCT for providing regular support to improve our daily practice and professional evaluation, and for critically reviewing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
CC has received speaker and consultancy fees from Terumo BCT and SANOFI SA. The remaining authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Drezet, A., Granata, A., Lemarie, C. et al. An intra-patient comparison of blood cell separators Spectra and Optia in patients and donors undergoing blood mononuclear cell collections at a single institution for subsequent autologous or allogeneic hematopoietic cell transplantation reveals comparable collection efficiencies. Bone Marrow Transplant 51, 1007–1009 (2016). https://doi.org/10.1038/bmt.2016.41
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2016.41